Gilead Licenses Novel Immunotherapy From Jounce

 
• By Joseph Haas
  
Brainstorming Group of people Working Concept. Business team brainstorming. Marketing plan researching. Paperwork on the table, laptop and mobile phone.
With its deal with Jounce, Gilead continues to pick up new IO partners

More from Deals

More from Business